Winton Group’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-119,676
Closed -$340K 575
2024
Q1
$340K Buy
+119,676
New +$340K 0.02% 514